
Home / Clinics / Joint & Musculoskeletal
Two large patient populations. One underserved clinic model. The chronic joint pain patient and the active individual seeking faster recovery are both searching — and in most U.S. markets, no dedicated regenerative clinic is answering them.
Book a Strategy CallThe first patient is 55, has chronic knee pain, and has been told their only option is a cortisone shot or eventual surgery. They are actively searching for a non-surgical alternative — platelet-rich plasma therapy, exosome injections, shockwave therapy — and finding very few local clinics.
The second patient is 38, trains regularly, and wants faster recovery from a shoulder injury. They know about PRP and BPC-157 peptide protocols and are willing to pay for results that get them back faster than physical therapy alone.
Both patients are searching in your market right now. A single well-positioned joint and musculoskeletal clinic serves both.
The patient who avoids surgery because of your clinic doesn't forget it. That outcome — and that gratitude — is the foundation of the referral engine that makes these clinics grow.
Age 45–70
Knee, hip, shoulder pain
Avoiding surgery
Referred by primary care
Age 25–50
Sports injuries, tendon issues
Faster recovery goal
Finds via search & community
Regenerative joint clinics remain significantly less competitive than medical weight loss or med spa in most U.S. markets. In most mid-sized markets, no dedicated clinic offers PRP, exosomes, and shockwave under one roof.
Concentrated growth factors from the patient's own blood — joint injections, tendon repair, and tissue regeneration. The category anchor service.
Cell-signaling exosomes injected locally into the joint, tendon, or ligament for accelerated tissue repair and inflammation reduction at the site of injury. Distinct from systemic IV exosomes (longevity context) or nebulized exosomes (neurological context). Premium positioning, strong clinical outcomes.
Acoustic wave therapy for tendinopathy, plantar fasciitis, and chronic musculoskeletal conditions. Equipment-based, low consumable cost, strong outcomes.
BPC-157 and TB-500 as injectable adjuncts to PRP and exosome protocols — accelerated tissue repair, joint recovery, and injury healing. Strong upsell from PRP with athletic patients. For peptide-first clinic models, see our Peptide Therapy page.
HBOT for accelerated recovery, inflammation reduction, and tissue healing. Premium add-on that elevates positioning with the sports recovery patient.
Photobiomodulation for tissue healing, pain reduction, and post-procedure recovery support. Complements every modality on this list.
From PRP equipment sourcing to Medical Director setup to the brand identity that makes patients choose you over the orthopedic surgeon next door — ACG builds every piece of the infrastructure before your first patient walks in.
Identify whether your market suits joint-focus, sports-recovery focus, or dual positioning — before committing capital.
Entity structure, state licensing, Medical Director introduction and oversight agreement for PRP and exosome procedures.
Shockwave equipment, PRP kits, HBOT, and exosome sourcing at preferred pricing through ACG's pre-vetted vendor network.
The non-surgical alternative positioning that converts the patient who was told surgery was their only option.
Grand opening execution and 60 days of continued ACG advisory — referral development, patient flow, and marketing.
Book a free strategy call. ACG will walk you through the joint and musculoskeletal opportunity in your specific market — competitive landscape, patient demand, and what the compliance and launch process looks like.
Book a Strategy CallFree 30-minute call · No pitch · ACG works with a select number of clients at any given time